Nathalia de Souza Rodrigues
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nathalia de Souza Rodrigues has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Charise Dallazem Bertol
Universidade de Passo Fundo, Brazil
3 shared publications - Tatiana Staudt
Universidade de Passo Fundo, Brazil
2 shared publications - Vitória Citolin Crestani
University of Passo Fundo. Passo Fundo; Brasil
2 shared publications - Ana Carolina Bertoletti De Marchi
Institute of Technology, University of Passo Fundo (UPF), Passo Fundo 99052-900, RS, Brazil
1 shared publication - Ana Caroline Tissiani
Universidade Regional Integrada do Alto Uruguai e das Missões
1 shared publication - Ana Luisa Sant’aNna Alves
Universidade de Passo Fundo, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Food Quality
- Vol. 2026 (1) , 8894384
Quality Assessment of Melatonin Supplements Marketed in Brazil: Alarming Discrepancies
Melatonin (MLT) is a hormone naturally produced by the pineal gland at night. It has multifunctional properties, including the regulation of circadian rhythms, antioxidant effects, and potential treatments for insomnia and jet lag. Due to simplified regulatory processes, many supplements may present quality deviations. In Brazil, MLT was recently approved for sale in pharmacies at low dosages. In this study, we analyzed the quality of orodispersible tablets containing 0.21 mg of MLT. Characterization was performed using Fourier‐transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), thermogravimetric analyses (TGA), and scanning electron microscopy (SEM) with an energy‐dispersive X‐ray spectrometer (EDS). A liquid chromatographic method with ultraviolet detection (LC/UV) was developed and validated, and used to perform the identification, assay, and content uniformity tests of the tablets. FTIR, DSC, and TGA analyses indicated excipient interference. SEM/EDS analysis revealed variations in formulation morphology and the presence of impurities, such as copper. The LC/UV method demonstrated precision, accuracy, and linearity, with a limit of detection (LOD) of 1.19 μg/mL and a limit of quantification (LOQ) of 3.98 μg/mL. Excipients and potential adulterants did not interfere with the specificity. Tablet weights ranged from 79 mg to 200 mg. The samples failed both the assay and content uniformity tests, with values ranging from 43% to 75% and from 30% to 78%, respectively. The low active ingredient content significantly compromises efficacy. These findings reinforce the need for standardization and increased regulatory oversight of dietary supplements to ensure efficacy and consumer safety.
- 1 January 2026
- Published by Wiley in Journal of Food Quality
- Vol. 2026 (1) , 8894384
Open AccessQuality Assessment of Melatonin Supplements Marketed in Brazil: Alarming Discrepancies
Melatonin (MLT) is a hormone naturally produced by the pineal gland at night. It has multifunctional properties, including the regulation of circadian rhythms, antioxidant effects, and potential treatments for insomnia and jet lag. Due to simplified regulatory processes, many supplements may present quality deviations. In Brazil, MLT was recently approved for sale in pharmacies at low dosages. In this study, we analyzed the quality of orodispersible tablets containing 0.21 mg of MLT. Characterization was performed using Fourier‐transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), thermogravimetric analyses (TGA), and scanning electron microscopy (SEM) with an energy‐dispersive X‐ray spectrometer (EDS). A liquid chromatographic method with ultraviolet detection (LC/UV) was developed and validated, and used to perform the identification, assay, and content uniformity tests of the tablets. FTIR, DSC, and TGA analyses indicated excipient interference. SEM/EDS analysis revealed variations in formulation morphology and the presence of impurities, such as copper. The LC/UV method demonstrated precision, accuracy, and linearity, with a limit of detection (LOD) of 1.19 μg/mL and a limit of quantification (LOQ) of 3.98 μg/mL. Excipients and potential adulterants did not interfere with the specificity. Tablet weights ranged from 79 mg to 200 mg. The samples failed both the assay and content uniformity tests, with values ranging from 43% to 75% and from 30% to 78%, respectively. The low active ingredient content significantly compromises efficacy. These findings reinforce the need for standardization and increased regulatory oversight of dietary supplements to ensure efficacy and consumer safety.
- 22 December 2025
- Published by Editora Acadêmica do Brasil in Revista Ciência & Humanização do Hospital de Clínicas de Passo Fundo
- Vol. 4 (1) , 52-64
Psicobióticos no tratamento da depressão e ansiedade
Objetivo: verificar a eficácia dos psicobióticos, um tipo de probiótico, no tratamento da depressão e da ansiedade, considerando a conexão entre o sistema nervoso e a microbiota intestinal. Métodos: foi realizada uma revisão sistemática, incluindo estudos de coorte e ensaios clínicos que avaliaram o uso de probióticos no tratamento desses transtornos. Resultados e Discussão: a análise incluiu 15 artigos. Os resultados indicaram que 100% dos indivíduos com depressão e ansiedade melhoraram seus sintomas. Além disso, 60% dos participantes com apenas ansiedade e 72,7% daqueles com apenas depressão também apresentaram melhorias. A maioria dos estudos teve baixo risco de viés, confirmando os benefícios dos psicobióticos. Conclusão: este estudo reforça a eficácia dos psicobióticos, destacando Bifidobacterium longum e Lactobacillus acidophilus, no tratamento da depressão e da ansiedade, ressaltando o papel do eixo intestino-cérebro. Ainda são necessárias mais pesquisas para confirmar esses achados.
- 22 December 2025
- Published by Editora Acadêmica do Brasil in Revista Ciência & Humanização do Hospital de Clínicas de Passo Fundo
- Vol. 4 (1) , 52-64
Psicobióticos no tratamento da depressão e ansiedade
Objetivo: verificar a eficácia dos psicobióticos, um tipo de probiótico, no tratamento da depressão e da ansiedade, considerando a conexão entre o sistema nervoso e a microbiota intestinal. Métodos: foi realizada uma revisão sistemática, incluindo estudos de coorte e ensaios clínicos que avaliaram o uso de probióticos no tratamento desses transtornos. Resultados e Discussão: a análise incluiu 15 artigos. Os resultados indicaram que 100% dos indivíduos com depressão e ansiedade melhoraram seus sintomas. Além disso, 60% dos participantes com apenas ansiedade e 72,7% daqueles com apenas depressão também apresentaram melhorias. A maioria dos estudos teve baixo risco de viés, confirmando os benefícios dos psicobióticos. Conclusão: este estudo reforça a eficácia dos psicobióticos, destacando Bifidobacterium longum e Lactobacillus acidophilus, no tratamento da depressão e da ansiedade, ressaltando o papel do eixo intestino-cérebro. Ainda são necessárias mais pesquisas para confirmar esses achados.
- Open Access
- 19 November 2025
- Published by Universidad Nacional de Misiones in Revista de Ciencia y Tecnología
- Vol. 44 (1) , 76-84
In vitro evaluations of warfarin tablets available in the brazilian market
The aging of the population has led to an increased use of anticoagulants such as sodium warfarin. This study evaluated the quality of 5 mg warfarin tablets by analyzing eight samples (A1–A8) in accordance with the Brazilian Pharmacopoeia, with the objective of identifying quality deviations and verifying their interchangeability with the referencemedication.The samples were subjected to the following quality control tests: average weight, friability (loss <1.5%), disintegration (within 30 minutes), dosing(content between 92.5% and 107.5%), and content uniformity (acceptance value <15). However, sample A3 failed the dissolution test, releasing less than 40% of the active ingredient within 30 minutes.The equivalence assessment indicated that samplesA1xA2 (69.97) and A1xA4 (54.43) were interchangeable, whereas samples A3, A5, A6, A7, and A8 were not.The comparison of dissolution profiles using the similarity factor (f₂) revealed that several samples exhibited quality deviations, potentially compromising treatment efficacy and safety, and suggesting deficiencies in Good Manufacturing Practices (GMP).
- 19 November 2025
- Published by Universidad Nacional de Misiones in Revista de Ciencia y Tecnología
- Vol. 44 (1) , 76-84
Open AccessIn vitro evaluations of warfarin tablets available in the brazilian market
The aging of the population has led to an increased use of anticoagulants such as sodium warfarin. This study evaluated the quality of 5 mg warfarin tablets by analyzing eight samples (A1–A8) in accordance with the Brazilian Pharmacopoeia, with the objective of identifying quality deviations and verifying their interchangeability with the referencemedication.The samples were subjected to the following quality control tests: average weight, friability (loss <1.5%), disintegration (within 30 minutes), dosing(content between 92.5% and 107.5%), and content uniformity (acceptance value <15). However, sample A3 failed the dissolution test, releasing less than 40% of the active ingredient within 30 minutes.The equivalence assessment indicated that samplesA1xA2 (69.97) and A1xA4 (54.43) were interchangeable, whereas samples A3, A5, A6, A7, and A8 were not.The comparison of dissolution profiles using the similarity factor (f₂) revealed that several samples exhibited quality deviations, potentially compromising treatment efficacy and safety, and suggesting deficiencies in Good Manufacturing Practices (GMP).